Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12042277 | 0.77 | POLB (0.46) | CNR1BACE1POLBALDH1A1MAPT | |
| SCHEMBL13216618 | 0.76 | TSHR (0.34) | POLB | |
| SCHEMBL16200785 | 0.71 | FPR2 (0.37) | CNR1POLBALDH1A1 | |
| SCHEMBL9257470 | 0.68 | — | — | |
| SCHEMBL23417578 | 0.67 | POLB (0.42) | CNR1BACE1POLBALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL829889 | 0.67 | MAPT (0.34) | ALDH1A1MAPT | |
| SCHEMBL22917251 | 0.67 | POLB (0.46) | CNR1BACE1POLBALDH1A1 | |
| SCHEMBL1919973 | 0.66 | KMT2A (0.60) | POLBALDH1A1MAPT | |
| SCHEMBL10065503 | 0.66 | CNR1 (0.32) | CNR1 | |
| SCHEMBL12028339 | 0.65 | POLB (0.49) | BACE1POLBALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7772433-B2 | SARMS and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2010-08-10 | — | — | US | disclosed |
| US-20080057068-A1 | SARMS and method of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080057068-A1 | SARMS and method of use thereof | SARM1, CKMT1A; CKMT1B, TNNI3 | CNR1 3329/4885BACE1 296/4885POLB 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.